A Biotech's Swelling Valuation

A Biotech's Swelling Valuation
The study determined that the drug is generally safe and well tolerated and that a 400mg dose three times daily can produce blood concentration levels that BioCryst thinks will be sufficient to get a clinical effect in patients with hereditary … Read more on Motley Fool

Small Stocks Crushing Their Index
Otherwise, we manage a low turnover by thoroughly vetting our stock picks—looking at the business, management, the capital structure—and buying at attractive levels. We look for companies that can sustain rapid profit growth, and focus on the long … Read more on Barron’s